TSF HealthScience has announced the appointment of Patrik Dursand to its Executive Committee as Chief People Officer. Bringing more than 15 years of experience across all facets of human resources…
Read More
We are excited to announce that we are strengthening our presence with the brand-new office in central London, in addition to the Uxbridge location. The office provides a modern and…
Strategic growth in the region brings TFS, a leading mid-size global CRO, to Research Triangle Park (RTP) to support an increasing demand for tailored and flexible solutions among the biotech…
TFS HealthScience has announced the appointment of Jesper Hjort as Chief Financial Officer. Joining from FLSmidth, a listed engineering company, Jesper brings over 14 years of finance experience across financial…
This accreditation enables TFS to address complex requirements characteristic of the current clinical research environment. Flexible approach and quick implementation of change helps us reach our clinical trial goals. As Medidata partner…
TFS has launched Connectify, a much-awaited Expert and Talent Network TFS is expanding its solutions offering to provide leadership, subject matter expertise and talent to our customers in the health…
Veeva Vault unifies clinical documents and processes to improve collaboration and speed execution Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience will be the first CRO to have selected Veeva Vault Clinical Operations…
TFS, a global CRO partnering with pharma and biotech companies, achieves EcoVadis Silver rating for sustainability. EcoVadis is the world’s largest and most trusted independent provider of business sustainability evaluating…
TFS has entered into a strategic partnership with the Duke Clinical Research Institute (DCRI) to provide data management solutions across the academic research organization’s study portfolio. The partnership supports TFS’s…
TFS is working in collaboration with sponsors, at an unprecedented pace. Our operational teams are participating in various studies, targeting coronavirus disease patients or analyzing the real world evidence to…
Technology continues to advance at an ever-increasing pace. As pressures rise to simultaneously reduce cost whilst increasing regulatory compliance, it is critical now more than ever, that such technologies are…
TFS Trial Form Support vient d’obtenir l’agrément Crédit d’Impôt Recherche (CIR) auprès du ministère en charge de la recherche pour ses travaux de recherche et de développement effectués pour ses…
[August 2021] Study results available First results from the COVID-Real study were published in BMJ https://www.ohdsi.org/bmj-drug-utilization-study/ This RWE study by TFS jointly with IOMED and OHDSI, describes 2,686 patients hospitalized…
Dear Customers and Vendors, As Chief Executive Officer at TFS, I wanted to take the opportunity to explain to you our approach to recent developments regarding the Coronavirus (COVID-19). Firstly,…
TFS attends ADCM Conference to present a TrialOnline ePRO – a custom patient retention tool developed in successful partnership between a CRO, EDC vendor and pharma. Patient retention represents an…